Astronics (Nasdaq: ATRO ) is expected to report Q1 earnings on May 6. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Astronics's revenues will grow 6.6% and EPS will wither -8.7%.
The average estimate for revenue is $69.4 million. On the bottom line, the average EPS estimate is $0.42.
Last quarter, Astronics reported revenue of $67.4 million. GAAP reported sales were 10% higher than the prior-year quarter's $61.2 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.37. GAAP EPS of $0.38 for Q4 were 12% higher than the prior-year quarter's $0.34 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 26.0%, 240 basis points worse than the prior-year quarter. Operating margin was 11.8%, 460 basis points worse than the prior-year quarter. Net margin was 8.4%, 10 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $300.4 million. The average EPS estimate is $1.78.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 294 members out of 308 rating the stock outperform, and 14 members rating it underperform. Among 60 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 57 give Astronics a green thumbs-up, and three give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Astronics is buy, with an average price target of $33.67.
Looking for alternatives to Astronics? It takes more than great companies to build a fortune for the future. Learn the basic financial habits of millionaires next door and get focused stock ideas in our free report, "3 Stocks That Will Help You Retire Rich." Click here for instant access to this free report.
- Add Astronics to My Watchlist.